Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes
- PMID: 28464427
- DOI: 10.1002/ejhf.860
Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes
Abstract
Aims: Pulmonary hypertension (PH) is a relevant complication of left heart disease (LHD). The 2015 ESC/ERS PH guidelines report two different haemodynamic subsets of PH due to LHD (PH-LHD) based on levels of pulmonary vascular resistance (PVR) and diastolic pressure gradient (DPG): isolated post-capillary PH (Ipc-PH) and combined post- and pre-capillary PH (Cpc-PH). The objective of this study is to evaluate the prognostic value of Ipc-PH and Cpc-PH.
Methods and results: Data from 276 consecutive incident patients with PH-LHD were included. According to the guidelines, Ipc-PH is defined by DPG <7 mmHg and/or PVR ≤3 Wood units (WU) and Cpc-PH by DPG ≥7 mmHg and/or PVR >3 WU. Using this definition, we identified three patient groups: Ipc-PH with both normal PVR and DPG (108 patients); Cpc-PH with both increased PVR and DPG (66 patients); and an intermediate group with either increased PVR or DPG (102 patients). Survival was estimated using the Kaplan-Meier method and compared between groups using the log-rank test. Patients with Ipc-PH had better survival compared with the group of patients with Cpc-PH (P = 0.026) and the intermediate group (P = 0.025). No survival difference was detected between patients with Cpc-PH and the intermediate group (P = 0.891). Patients with normal PVR had a better survival compared with those with elevated PVR (P = 0.012); while no difference was observed according to the level of DPG (P = 0.253).
Conclusion: Patients with Ipc-PH have a better prognosis compared with patients with Cpc-PH and with patients with isolated increase of PVR or DPG. Pulmonary vascular resistance has a better predictive value than DPG in patients with PH-LHD.
Keywords: Diastolic pressure gradient; Heart failure; Left heart disease; Pulmonary hypertension; Pulmonary vascular resistance.
© 2017 The Authors. European Journal of Heart Failure © 2017 European Society of Cardiology.
Comment in
-
Pulmonary vascular disease due to left heart disease: how to achieve a more accurate approach beyond the haemodynamic phenotype.Eur J Heart Fail. 2018 May;20(5):942-943. doi: 10.1002/ejhf.954. Epub 2017 Sep 26. Eur J Heart Fail. 2018. PMID: 28949088 No abstract available.
-
Pulmonary vascular disease due to left heart disease: how to achieve a more accurate approach beyond the haemodynamic phenotype: reply.Eur J Heart Fail. 2018 May;20(5):943. doi: 10.1002/ejhf.969. Epub 2017 Oct 11. Eur J Heart Fail. 2018. PMID: 29024373 No abstract available.
-
Pulmonary vascular indices and survival in left heart disease: illusion of conclusion?Eur J Heart Fail. 2018 Feb;20(2):256-259. doi: 10.1002/ejhf.1022. Epub 2017 Oct 19. Eur J Heart Fail. 2018. PMID: 29052305 No abstract available.
Similar articles
-
Significance of Pulmonary Vascular Resistance and Diastolic Pressure Gradient on the New Definition of Combined Post-Capillary Pulmonary Hypertension.Int Heart J. 2020;61(2):301-307. doi: 10.1536/ihj.19-476. Int Heart J. 2020. PMID: 32224602
-
Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.Eur J Heart Fail. 2018 Apr;20(4):725-734. doi: 10.1002/ejhf.1067. Epub 2017 Nov 16. Eur J Heart Fail. 2018. PMID: 29148140
-
Prognostic value and diagnostic properties of the diastolic pulmonary pressure gradient in patients with pulmonary hypertension and left heart disease.Int J Cardiol. 2019 Sep 1;290:138-143. doi: 10.1016/j.ijcard.2019.05.016. Epub 2019 May 13. Int J Cardiol. 2019. PMID: 31126737
-
The Diagnostic Challenge of Group 2 Pulmonary Hypertension.Prog Cardiovasc Dis. 2016 Jul-Aug;59(1):22-9. doi: 10.1016/j.pcad.2016.05.003. Epub 2016 May 16. Prog Cardiovasc Dis. 2016. PMID: 27195751 Review.
-
Revisiting Pulmonary Hypertension in the Era of Temporary Mechanical Circulatory Support - Literature Review and Case-Based Discussion.Transplant Proc. 2023 Dec;55(10):2462-2469. doi: 10.1016/j.transproceed.2023.09.022. Epub 2023 Nov 18. Transplant Proc. 2023. PMID: 37980253 Review.
Cited by
-
Outcomes of Preprocedural Pulmonary Hypertension on All-Cause and Cardiac Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation: A Systematic Review.Cureus. 2023 Jan 28;15(1):e34300. doi: 10.7759/cureus.34300. eCollection 2023 Jan. Cureus. 2023. PMID: 36860229 Free PMC article. Review.
-
Comparison of efficacy between sequential ventilation and conventional invasive mechanical ventilation in the treatment of pulmonary hypertension complicated with respiratory failure.Am J Blood Res. 2020 Oct 15;10(5):231-239. eCollection 2020. Am J Blood Res. 2020. PMID: 33224567 Free PMC article.
-
Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis.PLoS One. 2018 Oct 11;13(10):e0204610. doi: 10.1371/journal.pone.0204610. eCollection 2018. PLoS One. 2018. PMID: 30307953 Free PMC article.
-
A modified primary culture method of rat pulmonary vein smooth muscle cells.J Cardiothorac Surg. 2023 Apr 17;18(1):146. doi: 10.1186/s13019-023-02233-1. J Cardiothorac Surg. 2023. PMID: 37069582 Free PMC article.
-
Post-capillary pulmonary hypertension in heart failure: impact of current definition in the PH-HF multicentre study.Eur Heart J. 2024 Sep 14;45(35):3274-3288. doi: 10.1093/eurheartj/ehae467. Eur Heart J. 2024. PMID: 39056467 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials